Clinical Trial Update: Pilot Study to Evaluate the CereVasc® EShunt® System in the Treatment of Communicating Hydrocephalus [NA]

View source ↗

Summary

A pilot study evaluating the CereVasc EShunt System for treating communicating hydrocephalus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Communicating Hydrocephalus
• Hydrocephalus

Drugs mentioned

• CereVasc EShunt System

Snippet

Sponsor: CereVasc Inc | Conditions: Hydrocephalus, Hydrocephalus, Communicating | NA | Status: TERMINATED